Cargando…
Do We Need to Distinguish Thrombolysis and Nonthrombolysis Patients When Applying Stroke-Associated Pneumonia Predicting Scores? An External Validation from a 2-Center Database
BACKGROUND: Due to the lack of validation for predictive scoring of stroke-associated pneumonia in both thrombolysis- and nonthrombolysis-treated ischemic stroke (IS) patients, this study aimed to evaluate 4 scoring methods in the 2 subgroups. MATERIAL/METHODS: The CerebroVascular Database Project d...
Autores principales: | Jiao, Jiao, Geng, Leiyu, Zhang, Zhijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513614/ https://www.ncbi.nlm.nih.gov/pubmed/32921786 http://dx.doi.org/10.12659/MSM.924129 |
Ejemplares similares
-
When do we need to do meta-analysis!!!
por: Soni, Kapil D.
Publicado: (2023) -
When do we need a prophylactic treatment for asymptomatic bacteriuria?
por: Ecke, Thorsten H.
Publicado: (2013) -
When do we need clinical endpoint adjudication in clinical trials?
por: Held, Claes
Publicado: (2019) -
When applying GRADE, how do we decide the target of certainty of evidence rating?
por: Zeng, Linan, et al.
Publicado: (2021) -
Thrombolysis in Acute Pulmonary Embolism: Are we overdoing it?
por: Showkathali, Refai, et al.
Publicado: (2021)